Treatment with vatiquinone significantly slowed declines in upright stability among children and young adults with Friedreich’s ataxia (FA)…
Articles by Lindsey Shapiro, PhD
Use of the investigational therapy CTI-1601, now known as nomlabofusp, was associated with dose-dependent increases in levels of frataxin…
Diabetes, heart rhythm problems, and neurological disability were found to be the clinical factors most likely to influence life expectancy…
MRI imaging indicates that Friedreich’s ataxia (FA) patients have impairments in proprioception — sensory processing related to body movement…
Researchers are conducting a Phase 2 clinical trial to evaluate the safety, efficacy, and molecular effects of dimethyl fumarate…
Three mouse models of Friedreich’s ataxia (FA) do not accurately reflect FA-associated cardiomyopathy — a serious heart complication —…
Inducing oxidative stress — a type of cellular damage — into nerve cells of mice caused symptoms similar to those…
People with Friedreich’s ataxia (FA), regardless of age, have a thinner layer of nerve cells in the eye’s retina…
In-depth monitoring and prompt treatment enabled a man with Friedreich’s ataxia (FA) to successfully undergo a thyroidectomy — thyroid…
Disruptions to the DNA replication process during cell division may cause the expansion of FXN mutations that underlie Friedreich’s ataxia…